Cargando…

Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial

OBJECTIVE: To evaluate the efficacy and safety of atorvastatin (ATN) 80 mg in the prevention of contrast medium- induced nephropathy (CIN) in high risk patients undergoing angiograph. MATERIALS AND METHODS: This was a prospective, double-blind, two-arm, parallel group RCT. A total of 216 patients un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syed, Maaz Hussain, Khandelwal, Prakash Narayan, Thawani, Vijay R., Katare, S. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497399/ https://www.ncbi.nlm.nih.gov/pubmed/28706398 http://dx.doi.org/10.4103/jpp.JPP_156_16

Ejemplares similares

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015)

Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography
por: Sanei, Hamid, et al.
Publicado: (2014)

Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial
por: Khosravi, Arezoo, et al.
Publicado: (2016)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Atorvastatin facilitates protection against contrast-induced nephropathy in patients undergoing coronary angiography via humoral mediators rather than altered renal hemodynamics
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
por: Lee, Ji Hwan, et al.
Publicado: (2017)

The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial
por: Gholoobi, Arash, et al.
Publicado: (2015)

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2014)

Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
por: Assareh, Ahmadreza, et al.
Publicado: (2016)

Comparison of Normal Saline, Ringer's Lactate, and Sodium Bicarbonate for Prevention of Contrast-induced Nephropathy in Patients with Coronary Angiography: A Randomized Double-blind Clinical Trial
por: Pakfetrat, Maryam, et al.
Publicado: (2019)

Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography
por: Bei, Wei-Jie, et al.
Publicado: (2017)

Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020)

Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
por: Wang, Mian, et al.
Publicado: (2016)

Preventive Effect of Pretreatment with Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Angiography (PRINCIPLE Study)
por: Ko, Young-Guk, et al.
Publicado: (2013)

Impact of atorvastatin reload on the prevention of contrast-induced nephropathy in patients on chronic statin therapy: A prospective randomized trial
por: Hammami, Rania, et al.
Publicado: (2023)

Contrast-induced nephropathy following angiography and cardiac interventions
por: Rear, Roger, et al.
Publicado: (2016)

Furosemide with Saline Hydration for Prevention of Contrast-Induced Nephropathy in Patients undergoing Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials
por: Duan, Nana, et al.
Publicado: (2015)

Preventive effect of reduced glutathione on contrast-induced nephropathy in elderly patients undergoing coronary angiography or intervention: a randomized, controlled trial
por: Jin, B., et al.
Publicado: (2015)

Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial
por: Bell, Robert M., et al.
Publicado: (2013)

Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial
por: Iranirad, Leili, et al.
Publicado: (2017)

Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis
por: Bhatia, Amit, et al.
Publicado: (2020)

The efficacy of remote ischemic conditioning in preventing contrast‐induced nephropathy among patients undergoing coronary angiography or intervention: An updated systematic review and meta‐analysis
por: Zhan, Biming, et al.
Publicado: (2019)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
por: Sacha, Jerzy, et al.
Publicado: (2019)

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis
por: Bagshaw, Sean M, et al.
Publicado: (2004)

Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro
por: He, Xuyu, et al.
Publicado: (2017)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
por: Golshani, Samad, et al.
Publicado: (2022)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
por: Kimer, Nina, et al.
Publicado: (2020)

Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
por: Moini, Abdollatif, et al.
Publicado: (2012)

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial
por: Sayyah, Mehdi, et al.
Publicado: (2015)

Pentoxifylline and prevention of contrast-induced nephropathy: Is it efficient in patients with myocardial infarction undergoing coronary angioplasty?
por: Eshraghi, Ali, et al.
Publicado: (2016)

NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes
por: Beirne, Anne-Marie, et al.
Publicado: (2021)

The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
por: Wu, Zhijun, et al.
Publicado: (2015)

Contrast safety in the cancer patient: preventing contrast-induced nephropathy
por: Heiken, Jay P.
Publicado: (2008)

Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
por: Choi, Heejung, et al.
Publicado: (2012)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis
por: Liu, Ling-Yun, et al.
Publicado: (2018)

Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
por: Barbieri, Lucia, et al.
Publicado: (2022)

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention
por: Geenen, Remy W. F., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ci1t1agk3sopoditgmuigq2o84